使用凝血酶和生色底物H-D-苯丙氨酸-哌啶-精氨酸-对硝基苯胺（S-2238）测定血浆肝素。 - Suppr

Suppr

超能文献

Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238).

作者信息

Larsen M L, Abildgaard U, Teien A N, Gjesdal K

出版信息

Thromb Res. 1978 Aug;13(2):285-8. doi: 10.1016/0049-3848(78)90016-6.

DOI:10.1016/0049-3848(78)90016-6

PMID:567858

Abstract

摘要

相似文献

Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238).使用凝血酶和生色底物H-D-苯丙氨酸-哌啶-精氨酸-对硝基苯胺（S-2238）测定血浆肝素。

Thromb Res. 1978 Aug;13(2):285-8. doi: 10.1016/0049-3848(78)90016-6.

Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl.使用底物H-D-苯丙氨酸-哌啶-精氨酸-对硝基苯胺-2HCl半微量或自动测定凝血酶、抗凝血酶和肝素辅因子的方法。

Clin Chim Acta. 1977 Sep 15;79(3):595-602. doi: 10.1016/0009-8981(77)90181-4.

Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.抗凝血酶III对因子Xa肝素加速抑制作用存在血浆抑制剂的证据。

Biochim Biophys Acta. 1979 Sep 3;586(3):584-93. doi: 10.1016/0304-4165(79)90049-7.

Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.普通肝素对凝血酶催化的凝血放大反应的抑制作用比对Xa因子催化的反应更有效。

Biochem J. 1989 Jan 1;257(1):143-50. doi: 10.1042/bj2570143.

Serine protease specificity for peptide chromogenic substrates.丝氨酸蛋白酶对肽类生色底物的特异性。

Thromb Haemost. 1977 Dec 15;38(4):776-92.

Automated determination of heparin with chromogenic substrates.用显色底物自动测定肝素。

Haemostasis. 1984;14(2):184-94. doi: 10.1159/000215055.

Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.使用发色肽底物的抗凝血酶III活性简易检测法。手工法和自动化方法。

Scand J Haematol. 1983 Nov;31(5):427-36. doi: 10.1111/j.1600-0609.1983.tb01538.x.

Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.肝素治疗的监测。凝血酶时间、活化部分凝血活酶时间及血浆肝素浓度的比较，以及抗凝血酶III活性分析。

Am J Clin Pathol. 1980 Jul;74(1):68-73. doi: 10.1093/ajcp/74.1.68.

Determination of the biological activity of heparin by use of a chromogenic substrate.使用显色底物测定肝素的生物活性。

Thromb Haemost. 1980 Feb 29;42(5):1446-51.

[Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].[应用显色底物评估肾病综合征患者血浆中激肽释放酶-激肽系统和凝血系统指标]

Vopr Med Khim. 1983 Sep-Oct;29(5):96-9.

引用本文的文献

Fibers Generated by Plasma Des-AA Fibrin Monomers and Protofibril/Fibrinogen Clusters Bind Platelets: Clinical and Nonclinical Implications.血浆去氨基酸纤维蛋白单体和原纤维/纤维蛋白原聚集体产生的纤维可结合血小板：临床和非临床意义

TH Open. 2021 Jul 6;5(3):e273-e285. doi: 10.1055/s-0041-1725976. eCollection 2021 Jul.

Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity.使用抗Xa因子测定法优化肝素监测以及硫酸葡聚糖对测量所有药物活性的影响。

Biomedicines. 2021 Jun 21;9(6):700. doi: 10.3390/biomedicines9060700.

Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.检测凝血酶活性的纳米颗粒作为血栓形成的合成尿生物标志物。

ACS Nano. 2013 Oct 22;7(10):9001-9. doi: 10.1021/nn403550c. Epub 2013 Sep 12.

Detection of glycosaminoglycans on the surface of human umbilical vein endothelial cells using gold-conjugated poly-L-lysine with silver enhancement.使用金偶联聚-L-赖氨酸并通过银增强法检测人脐静脉内皮细胞表面的糖胺聚糖。

Histochem J. 1993 Apr;25(4):291-8. doi: 10.1007/BF00159120.

A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.三种低分子量肝素与糖胺聚糖抗凝血作用的交叉比较。

Br J Clin Pharmacol. 1993 Jul;36(1):51-6. doi: 10.1111/j.1365-2125.1993.tb05891.x.

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.肝素抑制血管平滑肌细胞增殖能力的结构决定因素。II. 含3-O-硫酸基团的五糖序列的证据。

J Cell Biol. 1986 May;102(5):1979-84. doi: 10.1083/jcb.102.5.1979.

The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.在人脐静脉内皮细胞培养物中添加内皮细胞生长因子和肝素可降低纤溶酶原激活物抑制剂-1的表达。

J Clin Invest. 1988 Aug;82(2):579-85. doi: 10.1172/JCI113635.

Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.静脉注射和口服低分子量肝素后血浆活性的研究。

Br J Clin Pharmacol. 1989 Aug;28(2):188-92. doi: 10.1111/j.1365-2125.1989.tb05415.x.

Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.给予健康老年志愿者低分子量类肝素Org 10172的安全性和药代动力学。

Br J Clin Pharmacol. 1989 Jan;27(1):39-48. doi: 10.1111/j.1365-2125.1989.tb05333.x.

Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.低分子量类肝素（Org 10172）与氯唑西林和替卡西林在健康男性志愿者体内相互作用的研究。

Antimicrob Agents Chemother. 1991 Oct;35(10):2110-5. doi: 10.1128/AAC.35.10.2110.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验